Frontiers in Oncology | Molecular and Cellular Oncology

Editorial

Published on 24 Jul 2023

Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients

in Molecular and Cellular Oncology

Zohreh Amoozgar
Mehdi Jaymand
Rana Jahanban-Esfahlan

Frontiers in Oncology

doi 10.3389/fonc.2023.1226974

1,612 views
5 citations

Review

Published on 21 Jul 2023

Current therapies and future prospective for locally aggressive mesenchymal tumors

in Molecular and Cellular Oncology

Alessandra Maleddu
Jessica Zhu
Michael Roy Clay
Breelyn Ann Wilky

Frontiers in Oncology

doi 10.3389/fonc.2023.1160239

3,342 views
3 citations

Original Research

Published on 20 Jul 2023

Non-coding RNAs and gastrointestinal cancers prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies

in Molecular and Cellular Oncology

Bowen Zha
Yuxi Luo
Muladili Kamili
Xiaqin Zha

Frontiers in Oncology

doi 10.3389/fonc.2023.1193665

1,441 views
1 citation

Editorial

Published on 19 Jul 2023

Editorial: Diverse roles of MAP4K4 in MAP kinase signaling and its implication for cancer therapeutics

in Molecular and Cellular Oncology

Ruchi Roy
Sunil Kumar Singh
Ajay Rana

Frontiers in Oncology

doi 10.3389/fonc.2023.1248808

1,515 views

Editorial

Published on 18 Jul 2023

Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume II

in Molecular and Cellular Oncology

João Pessoa
Maria Teresa Valenti
Nadège Bellance
Paula Chiarella
Tamrat Abebe
Lorenzo Gerratana
Carlos Pérez-Plasencia
Julia Kzhyshkowska

Frontiers in Oncology

doi 10.3389/fonc.2023.1242855

1,872 views

Original Research

Published on 18 Jul 2023

CCDC85A is regulated by miR-224-3p and augments cancer cell resistance to endoplasmic reticulum stress

in Molecular and Cellular Oncology

So Takahashi
Kurara Takagane
Go Itoh
Sei Kuriyama
Michinobu Umakoshi
Akiteru Goto
Kazuyoshi Yanagihara
Masakazu Yashiro
Katsunori Iijima
Masamitsu Tanaka

Frontiers in Oncology

doi 10.3389/fonc.2023.1196546

3,774 views
7 citations

Original Research

Published on 14 Jul 2023

Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment

in Molecular and Cellular Oncology

Giulio Giustarini
Germaine Teng
Andrea Pavesi
Giulia Adriani

Frontiers in Oncology

doi 10.3389/fonc.2023.1156769

7,896 views
7 citations

Original Research

Published on 14 Jul 2023

Nomogram incorporating potent inflammatory indicators for overall survival estimation of patients with primary oral squamous cell carcinoma

in Molecular and Cellular Oncology

Hai-xuan Wu
Shi Cheng
Fan Liu
Jun-jie Lin
Su-na Huang
Cheng-li Wang
Bin Zhou
Zhong-qi Liu
Ming-hui Cao

Frontiers in Oncology

doi 10.3389/fonc.2023.1197049

2,173 views
2 citations

Original Research

Published on 12 Jul 2023

Similar additive effects of doxorubicin in combination with photon or proton irradiation in soft tissue sarcoma models

in Molecular and Cellular Oncology

Teresa Bernardo
Carina Behrends
Diana Klein
Anna Kuntze
Beate Timmermann
Cläre von Neubeck

Frontiers in Oncology

doi 10.3389/fonc.2023.1211984

2,716 views
2 citations

Review

Published on 12 Jul 2023

Photodynamic therapy induced cell cycle arrest and cancer cell synchronization: review

in Molecular and Cellular Oncology

Kave Moloudi
Heidi Abrahamse
Blassan P. George

Frontiers in Oncology

doi 10.3389/fonc.2023.1225694

6,122 views
20 citations

Editorial

Published on 12 Jul 2023

Editorial: Overcoming the cell membrane to target intracellular oncoproteins

in Molecular and Cellular Oncology

Christopher J. Brown
Yong Li
Kanaga Sabapathy

Frontiers in Oncology

doi 10.3389/fonc.2023.1222095

1,304 views

Editorial

Published on 07 Jul 2023

Editorial: Strategies to overcome tumor evasion and resistance to immunotherapies by targeting immune suppressor cells

in Molecular and Cellular Oncology

Yu Saida
Satoshi Watanabe
Shohei Koyama
Yosuke Togashi
Toshiaki Kikuchi

Frontiers in Oncology

doi 10.3389/fonc.2023.1240926

2,155 views
2 citations

Review

Published on 07 Jul 2023

Characteristics and molecular mechanism of drug-tolerant cells in cancer: a review

in Molecular and Cellular Oncology

Xian-Wen Liang
Bing- Liu
Jia-Cheng Chen
Zhi Cao
Feng-ran Chu
Xiong Lin
Sheng-Zhong Wang
Jin-Cai Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1177466

4,637 views
11 citations

Brief Research Report

Published on 06 Jul 2023

Gain of chromosome 21 increases the propensity for P2RY8::CRLF2 acute lymphoblastic leukemia via increased HMGN1 expression

in Molecular and Cellular Oncology

Elyse C. Page
Susan L. Heatley
Jacqueline Rehn
Paul Q. Thomas
David T. Yeung
Deborah L. White

Frontiers in Oncology

doi 10.3389/fonc.2023.1177871

4,005 views
7 citations

Review

Published on 04 Jul 2023

Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target

in Molecular and Cellular Oncology

Nataliya Pidkovka
Abbes Belkhiri

Frontiers in Oncology

doi 10.3389/fonc.2023.1079041

3,294 views
5 citations

Original Research

Published on 04 Jul 2023

Copine 7 promotes colorectal cancer proliferation through PKM2 interaction and MAPK signaling pathway

in Molecular and Cellular Oncology

Tianwen Yu
Changhao Huang
Chen Lai
Qing He
Weijie Yuan
Zihua Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1166444

2,934 views
2 citations